Alfredo Pontecorvi Selected Research

Alfredo Pontecorvi Research Topics

Disease

55	Neoplasms (Cancer) 03/2024 - 01/2002
24	Acromegaly 05/2024 - 01/2007
21	Insulin Resistance 01/2023 - 01/2007
15	Thyroid Neoplasms (Thyroid Cancer) 02/2024 - 09/2008
14	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 07/2002
14	Type 2 Diabetes Mellitus (MODY) 01/2024 - 07/2010
12	Cushing Syndrome 11/2022 - 02/2007
11	Adenoma (Adenomas) 03/2024 - 05/2004
11	Pituitary Neoplasms (Pituitary Adenoma) 11/2023 - 03/2007
10	Inflammation (Inflammations) 07/2023 - 09/2009
9	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2024 - 11/2008
9	Papillary Thyroid Cancer 01/2021 - 05/2008
8	Neoplasm Metastasis (Metastasis) 02/2024 - 09/2008
7	Glucose Intolerance 09/2021 - 01/2007
7	Hypothyroidism 03/2021 - 11/2007
6	Carcinoma (Carcinomatosis) 03/2024 - 05/2004
6	Obesity 01/2023 - 10/2008
6	Adrenal Insufficiency (Adrenal Gland Hypofunction) 09/2018 - 01/2011
5	COVID-19 02/2024 - 05/2020
5	Osteoporosis 08/2023 - 09/2013
5	Infections 01/2023 - 01/2018
4	Goiter 01/2024 - 07/2011
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2023 - 01/2017
4	Hypophysitis 07/2023 - 10/2018
4	Graves Disease (Basedow Disease) 01/2023 - 08/2014
4	Hyperglycemia 01/2023 - 01/2017
4	Infertility (Sterility) 01/2022 - 09/2009
4	Diabetes Mellitus 01/2021 - 03/2008
4	Adrenocortical Carcinoma 02/2020 - 07/2012
4	Addison Disease (Addison's Disease) 01/2020 - 07/2012
4	Male Infertility (Male Sterility) 01/2020 - 01/2011
4	Body Weight (Weight, Body) 01/2019 - 12/2014
4	Hyperthyroidism 01/2019 - 04/2013
3	Primary Hyperparathyroidism 04/2024 - 01/2008
3	Hypoxia (Hypoxemia) 02/2024 - 01/2013
3	Disease Progression 01/2024 - 12/2013
3	Seminoma 11/2023 - 01/2019
3	Hypopituitarism (Sheehan's Syndrome) 07/2023 - 12/2011
3	Prolactinoma (Prolactinomas) 06/2021 - 12/2011
3	Fibrosis (Cirrhosis) 06/2021 - 08/2013
3	Thyroiditis 12/2020 - 01/2017
3	Thyroid Nodule (Nodule, Thyroid) 01/2020 - 05/2014
3	Anaplastic Thyroid Carcinoma 01/2020 - 04/2005
3	Hyperplasia 01/2018 - 07/2002
3	Pituitary ACTH Hypersecretion 03/2017 - 02/2007

Drug/Important Bio-Agent (IBA)

17	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 01/2007
14	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2024 - 01/2007
14	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2005
12	Insulin (Novolin)FDA Link 09/2023 - 01/2007
11	Biomarkers (Surrogate Marker)IBA 11/2023 - 05/2009
11	Growth Hormone (Somatotropin)IBA 01/2023 - 03/2008
11	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2022 - 05/2010
10	Hormones (Hormone)IBA 03/2024 - 10/2008
10	Estrogens (Estrogen)FDA Link 02/2024 - 07/2002
10	Vitamin D FDA LinkGeneric 08/2023 - 07/2010
10	Insulin-Like Growth Factor I (IGF-1)IBA 01/2023 - 01/2007
10	pasireotideIBA 01/2023 - 03/2007
10	pegvisomant FDA LinkGeneric 12/2022 - 01/2007
10	Testosterone (Sustanon)FDA Link 01/2020 - 11/2008
9	AndrogensIBA 03/2024 - 07/2002
9	GlucocorticoidsIBA 07/2023 - 09/2013
8	AntioxidantsIBA 12/2022 - 01/2007
7	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2021 - 03/2007
6	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2022 - 02/2007
6	ProteomeIBA 01/2022 - 01/2012
6	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2021 - 04/2013
5	ProlactinIBA 01/2023 - 09/2009
5	LigandsIBA 02/2021 - 03/2007
5	coenzyme Q10 (CoQ10)IBA 01/2018 - 10/2008
4	Thyroglobulin FDA Link 11/2023 - 04/2005
4	Protein Isoforms (Isoforms)IBA 02/2021 - 06/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2013
4	Estrogen ReceptorsIBA 01/2020 - 07/2002
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2020 - 09/2009
4	Messenger RNA (mRNA)IBA 02/2017 - 07/2002
3	Parathyroid Hormone (Parathormone)IBA 04/2024 - 01/2008
3	Tyrosine Kinase InhibitorsIBA 03/2024 - 01/2020
3	Cadherins (E-Cadherin)IBA 02/2024 - 10/2022
3	AntigensIBA 01/2024 - 01/2018
3	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2022
3	AutoantibodiesIBA 07/2023 - 01/2019
3	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 09/2021
3	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2020
3	LDL CholesterolIBA 02/2022 - 10/2010
3	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 07/2002
3	Galectin 3 (LGALS3)IBA 01/2021 - 09/2011
3	hydroxide ionIBA 12/2020 - 10/2010
3	Mitotane (Lysodren)FDA Link 02/2020 - 07/2012
3	Insulin-Like PeptidesIBA 01/2020 - 06/2016
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 06/2018 - 03/2011
3	Estrogen Receptor betaIBA 06/2018 - 05/2009
3	25-hydroxyvitamin DIBA 11/2017 - 10/2010
3	ChromatinIBA 01/2017 - 01/2013

Therapy/Procedure

42	Therapeutics 05/2024 - 02/2007
15	Thyroidectomy 02/2024 - 09/2008
7	Adrenalectomy 11/2022 - 02/2007
5	Drug Therapy (Chemotherapy) 07/2023 - 01/2019
4	Pancreaticoduodenectomy 01/2021 - 06/2013
3	Immunotherapy 10/2023 - 01/2020
3	Radiotherapy 01/2023 - 02/2007